Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Collegium Pharmaceutical (COLL) Other Non-Current Liabilities (2016 - 2025)

Historic Other Non-Current Liabilities for Collegium Pharmaceutical (COLL) over the last 5 years, with Q3 2025 value amounting to $19000.0.

  • Collegium Pharmaceutical's Other Non-Current Liabilities fell 9953.61% to $19000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $19000.0, marking a year-over-year decrease of 9953.61%. This contributed to the annual value of $1.2 million for FY2024, which is N/A changed from last year.
  • Collegium Pharmaceutical's Other Non-Current Liabilities amounted to $19000.0 in Q3 2025, which was down 9953.61% from $38000.0 recorded in Q2 2025.
  • In the past 5 years, Collegium Pharmaceutical's Other Non-Current Liabilities registered a high of $4.1 million during Q3 2024, and its lowest value of $19000.0 during Q3 2025.